Advertisement

Topics

Search Results for "Elisa For Avastin"

14:53 EST 2nd December 2016 | BioPortfolio

Matching Channels

None

Matching News

Quick and easy: new ELISA for plant virus detection

Scientists at the Leibniz Institute DSMZ have developed an extremely timesaving immunoassay variant. Using the classic ELISA, results are obtained only after up to two days. However, the new 'B-Fast E...

Case study on human α1‐antitrypsin: Recombinant protein titers obtained by commercial ELISA kits are inaccurate

Accurate titer determination of recombinant proteins is crucial for evaluating protein production cell lines and processes. Even though enzyme‐linked immunosorbent assay (ELISA) is the most widely u...

EU approval for Avastin/Tarceva combination for specific type of advanced lung cancer

The European Commission has approved the use of Swiss pharma giant Roche’s Avastin (bevacizumab) in…

Boehringer Ingelheim’s Biosimilar Candidate Demonstrates Bioequivalence to Avastin

INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced new data from the Phase I INVICTAN®-1 study, which show that BI 695502, its bevacizumab biosimilar candidate, is bi...

BLA for Avastin biosimilar filed by Amgen, Allergan

A biologics license application for a biosimilar version of Roche Holding's Avastin, or bevacizumab, has been submitted to th -More- 

Litigation Aside Biosimilar Avastin Just Got Cheaper In India

Another biosimilar version of Roche's anticancer, Avastin (bevacizumab) has just arrived on the Indian market despite the shadow of ongoing...  

Allergan, Amgen submit application for possible Avastin biosimilar

David Salazar The companies said their biosimilar candidate, ABP 215, is the most advanced of the four oncologic biosimilars they are developing, and they believe it’s the first submission for ...

Amgen, Allergan submit Avastin biosimilar

Amgen Inc. (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) said they submitted a BLA to FDA for ABP 215, a biosimilar of Avastin bevacizumab from the Genentech unit of

Matching PubMed Articles

ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.

Aberrant glycosylation of target glycoprotein is a frequent and significant event involved in many cancers, for example, increased fucosylated haptoglobin (Hp) in hepatocellular carcinoma (HCC). The n...

Detection of Helicobacter pylori by Real-Time PCR for 16s rRNA in Stools of NonInfected Healthy Children, Using ELISA Antigen Stool Test as the Gold Standard.

We previously detected Helicobacter pylori infection by stool antigen ELISA assay in 33-41% of asymptomatic Chilean children between 2-3 years of age, of which 11-20% had a transient infection and 21-...

Comparative Diagnosis of Serum IgG1 and Coproantigen ELISA for Fasciolosis Detection of Goats in Mexico.

The objective of present study was to determine the prevalence of natural caprine fasciolosis in the Mixteca region of Mexico using coproantigen and serum IgG1 ELISA tests for comparative purposes. A ...

Case study on human α1-antitrypsin: Recombinant protein titers obtained by commercial ELISA kits are inaccurate.

Accurate titer determination of recombinant proteins is crucial for evaluating protein production cell lines and processes. Even though enzyme-linked immunosorbent assay (ELISA) is the most widely use...

ELISA reader does not interfere by mobile phone radiofrequency radiation.

The increasing number of mobile phones can physically cause electromagnetic interference (EMI) in medical environments; can also cause errors in immunoassays in laboratories. The ELISA readers are wid...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement